Try our beta test site
419 studies found for:    university of tennessee health science center | Open Studies | United States, Tennessee
Show Display Options
Rank Status Study
1 Recruiting Obstetrical Repository of Biological Materials
Condition: Health Problems in Pregnancy
2 Recruiting IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D
Conditions: Abscess;   Pain
Interventions: Drug: intranasal ketamine;   Drug: intranasal fentanyl;   Drug: intranasal midazolam
3 Recruiting Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
Conditions: Urinary Tract Infection;   Vesicoureteral Reflux
Intervention: Drug: Sulfur hexafluoride type-a lipid microspheres
4 Recruiting Electronic Application of a Severe Sepsis Screening Tool and Management Bundle
Conditions: Systemic Inflammatory Response Syndrome (SIRS);   Sepsis;   Severe Sepsis;   Septic Shock
Intervention: Other: Severe Sepsis Management Bundle
5 Recruiting Male Fertility and Sperm Cryopreservation
Conditions: Fertility;   SPERM;   Cancer
Intervention: Procedure: Sperm and blood collected for analysis
6 Recruiting Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit
Condition: Smoking Cessation
Interventions: Behavioral: Brief Advice;   Behavioral: Motivational Interviewing;   Behavioral: Rate Reduction;   Drug: Pharmacological;   Behavioral: MI+RR
7 Recruiting Beta Blockade in in Traumatic Brain Injury
Condition: Brain Injuries, Traumatic
Intervention: Drug: Propranolol
8 Recruiting Post-Operative Gynecological Oncology App Study
Condition: Genital Neoplasm, Female
Interventions: Behavioral: Discharge instructions reminders;   Behavioral: Prompts to report symptoms via the web-enabled app;   Behavioral: Clinical Alerts
9 Not yet recruiting Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
Conditions: Melanoma;   BRAF Gene Mutation
Interventions: Drug: Talimogene Laherparepvec 1 Million Pfu/Ml Inj,Susp,1Ml,Vil;   Drug: Talimogene Laherparep 100 Mil Pfu/Ml 1Ml;   Drug: Dabrafenib;   Drug: Trametinib
10 Recruiting Light Therapy to Increase Energy in Adolescents and Young Adults Newly Diagnosed With Solid Tumors: A Pilot Study
Conditions: Neoplasms;   Fatigue
Interventions: Device: Bright White Light;   Device: Dim Red Light
11 Recruiting Voice Therapy in Parkinson Disease
Condition: Parkinson Disease
Interventions: Other: Transcranial Magnetic Stimulation;   Behavioral: Lee Silverman Voice Treatment
12 Recruiting The Management of Diabetes in Everyday Life Program
Conditions: Diabetes Mellitus;   Chronic Disease
Interventions: Behavioral: Text Messaging (TM);   Behavioral: Health Coaching (HC);   Behavioral: Enhanced Usual Care (EC)
13 Recruiting Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: ursodeoxycholic acid (UDCA)
14 Recruiting Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis
Condition: Candidemia
Interventions: Drug: Anidulafungin;   Drug: Fluconazole
15 Recruiting Tissue Samples and Bodily Fluid Specimens Banking
Condition: Endocrine Disorders of Female Reproductive System
Intervention: Procedure: collect body fluids/tissues & med history
16 Recruiting Characteristics of Women With Reproductive Concerns
Condition: Endocrine Disorders of Female Reproductive System
17 Recruiting Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
Condition: Epilepsies, Partial
Interventions: Drug: Lyrica (pregabalin);   Drug: placebo
18 Recruiting S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: everolimus;   Drug: exemestane;   Drug: goserelin acetate;   Drug: letrozole;   Drug: leuprolide acetate;   Drug: tamoxifen citrate;   Other: placebo
19 Recruiting S0820, Adenoma and Second Primary Prevention Trial
Condition: Colorectal Neoplasms
Interventions: Drug: Eflornithine placebo & sulindac placebo;   Drug: eflornithine & sulindac placebo;   Drug: Eflornithine placebo & sulindac;   Drug: Eflornithine plus sulindac
20 Recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Ductal Breast Carcinoma In Situ;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Invasive Breast Carcinoma;   Multicentric Breast Carcinoma;   Multifocal Breast Carcinoma;   Synchronous Bilateral Breast Carcinoma
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Drug: Systemic Chemotherapy;   Drug: Tamoxifen Citrate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.